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Initiation of Signal Transduction
through the T Cell Receptor Requires the
Multivalent Engagement of Peptide/MHC Ligands
are themselves membrane-associated molecules (MHC)
that are complexed with antigenic peptides (Ag). Sec-
ond, the affinities of TCRs for Ag/MHC complexes are
generally low (with KDs from 1027 to 1024 M) (reviewed
in Davis et al., 1998). Third, T cells contain coreceptors
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that bind MHC molecules independent of antigen and2 Howard Hughes Medical Institute
3 Department of Chemistry contribute to signaling by bringing the protein Tyr kinase
p56lck to the site of TCR engagement (Shaw et al., 1990;Stanford University
Stanford, California 94305 Turner et al., 1990). Lastly, the TCR complex, which con-
tains no intrinsic enzymatic activity, contains three other
apparent dimers, CD3ge, CD3de, and a z homodimer,
that possess sites for Tyr phosphorylation and substrateSummary
binding but organize in an unknown manner with respect
to each other and to the TCR itself (reviewed in Alberola-While much is known about intracellular signaling
Ila et al., 1997).events in T cells when T cell receptors (TCRs) are
engaged, the mechanism by which signaling is initi-
ated is unclear. We have constructed defined oligo- Results
mers of soluble antigen-major histocompatibility com-
plex (MHC) molecules, the natural ligands for the TCR. BIAcore Characterization of MHC Oligomers
Using these to stimulate specific T cells in vitro, we To address the molecular mechanism of signaling through
find that agonist peptide/MHC ligands are nonstimula- the TCR, we have constructed oligomers of a soluble
tory as monomers and minimally stimulatory as di- form of a singly C-terminally biotinylated murine class
mers. Similarly, a partial-agonist ligand is very weakly II MHC molecule, IEk (Altman et al., 1993; GuÈ tgemann
active as a tetramer. In contrast, trimeric or tetrameric et al., 1998), by linking it at different valencies to a strep-
agonist ligands that engage multiple TCRs for a sus- tavidin molecule (Altman et al., 1996). Moth cytochrome
tained duration are potent stimuli. Ligand-driven for- c peptide (MCC) bound to IEk is recognized by the well
mation of TCR clusters seems required for effective characterized T cell hybridoma, 2B4 (Hedrick et al.,
activation and helps to explain the specificity and sen- 1982; Samelson et al., 1983). MCC/IEk-only (no streptavi-
sitivity of T cells. din) and MCC/IEk monomer (one MCC/IEk per streptavi-
din) bind a soluble form of the 2B4 TCR with similarly
transient kinetics (Figure 1A) (Davis et al., 1998). As ex-Introduction
pected, MCC/IEk dimers and tetramers bind much more
tightly to the TCR surface with dissociation rates ap-In general, upon ligand binding, a cell surface receptor
proximately 10- and 170-fold slower, respectively, indi-initiates a signaling cascade inside of a cell by either
cating that each MCC/IEk molecule is functionally activeundergoing a conformational change or by clustering.
(Figure 1A). The binding of bivalent antibodies and theirWhile it has been clear for many years that cross-linking
monovalent Fab fragments to cells also differs by ap-of TCR complexes can cause T cell activation (Kappler
proximately 10-fold in off rate (Mason and Williams,et al., 1983; Kaye et al., 1983; Meuer et al., 1983; Watts,
1986). We also analyzed the binding to the 2B4 TCR of1988; Symer et al., 1992; Kolanus et al., 1993; Spencer
IEk containing the partial agonist peptide, MCC(102S).et al., 1993), it has remained controversial whether the
This peptide contains a Thr to Ser substitution at a TCRbinding of a single TCR by its natural ligand is sufficient
contact site that reduces its activity approximately 100-as well (Karjalainen, 1994; Takahama et al., 1994). More-
fold in in vitro T cell activation assays (Matsui et al.,over, if receptor clustering is required, the number of
1994). As shown in Figure 1B, the monomer dissociatesTCR molecules that are necessary to make a productive
from the 2B4 TCR about 7-fold faster than MCC/IEk (Fig-signaling unit is unclear. In the case of TCRs, distinguish-
ure 1B) (Matsui et al., 1994; Lyons et al., 1996). Likewise,ing between these two signaling mechanisms has been
the MCC(102S)/IEk tetramer has a half-life approximatelydaunting for several reasons. First, their natural ligands
13-fold shorter than the MCC/IEk tetramer, more closely
resembling the MCC/IEk dimer (Figure 1B).4 To whom correspondence should be addressed (e-mail: mdavis@
By virtue of their dual specificity, the oligomeric MHCcmgm.stanford.edu).
complexes used above contain different valencies of5 Present address: Eos Biotechnology, Inc., 225A Gateway Boule-
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ton, Box 351700, Seattle, WA 98195±1700. 1996) and when complexed with IEk has an affinity for
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Table 1. Representative t1/2 Values for the Binding of MCC/IEk
Complexes to 2B4 TCR
t1/2 Values at 258C
Analyte Low-Density TCR High-Density TCR
MCC/IEk 12.0 sec 11.0 sec
MCC/IEk monomer 9.5 sec
MCC/IEk dimer 1.7 min 3.1 min
MCC/IEk tetramer 13.9 min 32.0 mina
MCC(102S)/IEk 1.5 secb
MCC(102S)/IEk tetramer 2.4 min
MCC/IEk monomerc 10.0 sec 14.0 sec
MCC/IEk dimerc 1.9 min 3.4 min
MCC/IEk trimerc 8.3 min 17.0 min
a MCC/IEk tetramer off rates show the most variability, possibly due
to a greater dependence on TCR density, a higher probability of
rebinding, and apparent perturbations in the properties of the hy-
drogel dextran matrix caused by extensive cross-linking. The latter,
which is observed occasionally, is evidence by a nearly flat dissocia-
tion phase for the first 2 to 3 min of dissociation followed by more
rapid dissociation. Half-lives determined for such curves can be as
long as 120 min.
b Data taken from Lyons et al. (1996).
c These complexes refer to MCC(99A)/IEk mixed oligomers.
Flow cells contained 3,000±4,000 and 8,000 RU of bound TCR for
low- and high-density surfaces, respectively.
and tetramer (Figure 1C). No binding was observed with
tetramers of either MCC(99A)/IEk or MCC(102G)/IEk at
concentrations up to 450 mg/ml (data not shown).
MCC(102G) antagonizes the MCC response of the 2B4
hybridoma and when complexed with IEk binds the 2B4
TCR with an affinity approximately 30-fold lower than
MCC (Lyons et al., 1996). A summary of BIAcore-derived
half-lives is given in Table 1.
Cytosensor Microphysiometer Analysis
of T Cell Activation
To have as rapid a readout of T cell activation as possi-
Figure 1. BIAcore Binding Analysis of IEk Oligomers to the 2B4 TCR ble, we first followed extracellular acidification of T cells
(A) MCC/IEk complexes were passed over 2B4 TCR coupled to the using the Cytosensor microphysiometer (McConnell et
sensor chip. Shown is the binding of MCC/IEk-only (open squares), al., 1992), which detects cellular activation within min-
MCC/IEk monomer (open circles), dimer (solid squares) at 33 mg/ml, utes of stimulation and which has been used to charac-
and tetramer (solid circles) at 72 mg/ml.
terize MCC-specific T cells, such as 5C.C7 (Beeson et(B) Shown is the binding of MCC/IEk-only (33 mg/ml) (open squares),
al., 1996; Rabinowitz et al., 1996b). The 5C.C7 and 2B4MCC(102S)/IEk (200 mg/ml) (solid circles), and MCC(102S)/IEk tetra-
TCRs both use Va11 and Vb3 gene segments (Chien etmer (100 mg/ml) (solid squares).
(C) Shown is the binding of the mixed oligomers containing al., 1984; Becker et al., 1985; Fink et al., 1986) and show
MCC(99A)/IEk in the residual biotin binding sites. Binding was per- similarly fine antigen specificity (Hedrick et al., 1982;
formed at 72 mg/ml monomer (open squares), dimer (open circles), Reay et al., 1994). The MCC/IEk tetramer is a potent
trimer (solid squares), and tetramer (solid circles). Dissociation rates
stimulator of 5C.C7 T cells, giving half-maximal re-appear faster in (C) because the TCR surface is only half as dense
sponse at 0.1 mg/ml (Figure 2A). Detectable T cell activa-as in (A) and (B). In (A) and (B), concentrations refer to the amount
tion occurred with as little as 10 ng/ml tetramer (dataof MCC/IEk but in (C) they refer to the amount of total IEk [MCC and
MCC(99A)]. No binding was observed with streptavidin only. not shown). Stimulation by the MCC/IEk dimer is barely
detectable at 2 mg/ml and is still less effective at 20
mg/ml than 0.1 mg/ml tetramer (Figure 2A). We cannot
exclude the possibility that small amounts of contami-the 2B4 TCR too low to measure. Here, the nomenclature
refers to the number of MCC/IEk molecules (ªmonomer,º nating tetramer and trimer account for at least some
of the activity of dimer (see Experimental Procedures).for example, refers to one MCC/IEk and three MCC(99A)/
IEk). The binding of monomers and dimers prepared this MCC/IEk monomer was inactive at 20 mg/ml (Figure 2A),
and in two separate experiments no detectable signalway is very similar to those without MCC(99A), indicating
that even when tightly associated with an active peptide/ occurred with MCC/IEk-only at a concentration of 200
mg/ml (data not shown). The tetramer containing theMHC complex, MCC(99A)/IEk contributes very little TCR
binding energy (Figure 1C). As expected, the trimer dis- partial agonist peptide MCC(102S) stimulates the 5C.C7
T cells weakly at a concentration of 20 mg/ml, while thesociates at a rate intermediate between MCC/IEk dimers
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Figure 2. Cytosensor Analysis of T Cell Activation by MCC/IEk Figure 3. Cytosensor Analysis of T Cell Activation by Mixed
Oligomers Oligomers
(A) Shown is the 5C.C7 T cell response to MCC/IEk monomer at 20 (A) Shown is the 5C.C7 T cell response to the mixed oligomers
mg/ml (open diamonds), MCC/IEk dimer at 2 mg/ml (open squares) containing both MCC and MCC(99A) for monomer (open circles),
and 20 mg/ml (closed triangle), and MCC/IEk tetramer at 0.1 mg/ dimer (closed triangles), trimer (open squares), and tetramer (closed
ml (open circles), 0.5 mg/ml (closed circles), and 2 mg/ml (closed squares) at 0.5 mg/ml. Also shown is the response to 20 mg/ml
squares). (B) Shown is the 5C.C7 response to MCC(102G)/IEk tetra- MCC(99A)/IEk tetramer (open diamonds).
mer (open diamonds), MCC(102S)/IEk tetramer (closed triangles), (B) Shown is the 2B4 T cell response using same complexes and
and MCC/IEk tetramer (closed squares), at 20, 20, and 0.5 mg/ml, symbol codes as in (A) except that the concentrations were 1 mg/
respectively. Also shown is the response to MCC(102S)/IEk tetramer ml for all samples except MCC(99A)/IEk tetramer, which was at 20
(open squares) and MCC/IEk tetramer (open circles) at 20 and 0.5 mg/ml. Concentrations refer to the amount of MCC/IEk.
mg/ml, respectively, following pretreatment of cells with 20 mg/ml
GK1.5 antibody. Oligomer concentrations refer to the amount of
MCC/IEk. Maximal response of 5C.C7 cells was approximately 300%
less than tetramer in the binding assay, is also markedlyusing anti-CD3e antibody (clone 145±2C11), which should oligo-
merize TCR (Punt et al., 1994). less active (Figure 3A). No activation was observed with
MCC(99A)/IEk tetramer at 10 mg/ml (Figure 3A). Experi-
ments with these complexes were also performed withtetramer containing the MCC(102G) peptide-antagonist
a 2B4 T cell line with similar results (Figure 3B). The factwas inactive at this concentration (Figure 2B). Together,
that the MCC(99A)/IEk complex could not substitute forthese last results indicate that specificity is maintained
MCC/IEk indicates that CD4 binding alone is not suffi-in this system.
cient for T cell stimulation.To determine whether this stimulation is CD4 depen-
dent, 5C.C7 T cells were incubated with tetramers of
Calcium Flux MeasurementsMCC/IEk or MCC(102S)/IEk with or without pretreatment
To further characterize the T cell signal delivered bywith an anti-CD4 antibody (clone GK1.5). GK1.5 com-
tetrameric MCC/IEk, calcium flux was measured at thepletely blocks the response to 0.5 mg/ml of MCC/IEk
single cell level for both 5C.C7 and 2B4 T cells (Figuretetramer (Figure 2B) and reduces the signal arising from
4; Table 2). While a commitment to full activation is50 mg/ml of MCC/IEk tetramer by 60%±70% (data not
characterized by a high and sustained level of calciumshown), indicating that CD4 is involved. This is consis-
(WuÈ lfing et al., 1997), only transient elevations are ob-tent with the lack of T cell activation that occurs by
served in T cells activated with tetramer at concentra-antibody-induced cross-linking of TCR in cells deficient
tions as high as 250 mg/ml (Figure 4; Table 2). Activationin p56lck (Molina et al., 1992; Straus and Weiss, 1992).
above background is seen at tetramer concentrationsLikewise, the response to MCC(102S)/IEk tetramer is
as low as 100 ng/ml (Table 2). As a further control forinhibited with GK1.5 by more than 90%, indicating that
specificity, we also found that a hemoglobin (Hb)-spe-its relatively poor activity is not due to lack of CD4
cific T cell line was activated by Hb-peptide/IEk tetramerrecruitment (Figure 2B).
but not MCC/IEk tetramer (Table 2). Overall, we concludeIn Figure 3A, the response of 5C.C7 T cells to the
that while the MCC/IEk tetramer is sufficient to initiatemixed oligomers containing MCC and MCC(99A) is
signaling, further TCR cross-linking may be necessaryshown. As is true without MCC(99A) substitution, mono-
for sustained full signals. This conclusion is supportedmer and dimer are inactive or very weakly active, respec-
by the ability of MCC/IEk complexes on planar mem-tively, at the concentrations tested (Figure 3A). The tri-
mer, although exhibiting a half-life that is only 2-fold branes to induce a sustained calcium flux with these
Immunity
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Table 2. Summary of Calcium Flux Data
Cells Responding (%) and Type of
Calcium Signal
Stimulus Cell Full Partial None
MCC/APC 5CC7a 90±95 0 5±10
MCC(102S)/APC 5CC7a 80±95 5±20 5±10
MCC/IEk tetramer
250 mg/ml 5CC7 0 77 23
10±100 mg/ml 2B4 0.8 61 39
0.1 mg/ml 2B4 0 18.5 81.5
Hb/APC PL-17b 50±85 0 15±50
MCC/IEk tetramer PL-17 0 12 88
Hb/IEk tetramer PL-17 0 50 50
a Taken from WuÈ lfing et al. (1997). The range in percentages occurs
for peptide concentrations of 25 nM to 25 mM.
b PL-17 is a T cell line that is specific for a hemoglobin peptide
presented by IEk (Evavold et al., 1992). The range in percentages
occurs for peptide concentrations of 100 nM to 100 mM in a single
Figure 4. Single Cell Calcium Flux of 5CC7 T Cells experiment.
(A) Shown is a representative trace of calcium fluctuations in a 5C.C7 The percentage of stimulation by MCC/IEk tetramer at 250 mg/ml
T cell at 378C treated with MCC/IEk tetramer at a concentration of was for a single experiment, at 10±100 mg/ml is an average of four
250 mg/ml. experiments, and at 0.1 mg/ml is an average of two experiments.
(B) Shown for comparison is a typical calcium response to stimula- Background level of calcium signals was always 10% or less.
tion by MCC peptide presented on CHO cells transfected with IEk
at 258C as described in WuÈ lfing et al. (1997). At 258C, the response
to tetramer was generally more lagged than that shown at 378C. on Ag/MHC-TCR complexes show no evidence of global
structural changes in the TCR upon binding (Garboczi
et al., 1996; Garcia et al., 1998).same T cells (WuÈ lfing et al., 1998). In an APC-T cell
conjugate, TCRs and signaling elements can concen- Because biotin binding sites in streptavidin are ar-
ranged in a tetrahedral configuration (Pahler et al., 1987),trate within contact patches, while tetramer-ligated
TCRs should at least initially be uniformly distributed, three of four MCC/IEk molecules should form one face
of a tetrahedron and contact the T cell surface (as mod-possibly diluting limiting amounts of an initiation kinase,
as has been shown to occur for the IgE receptor (Torigoe eled by McMichael and O'Callaghan, 1998). Thus, the
ability to stabilize the colocalization of two or three TCRset al., 1997).
can explain the tetramers striking potency. Neverthe-
less, the possibility that activation occurs because TCRsDiscussion
are ligated for longer periods of time, as opposed to
clustering per se, cannot be formally excluded. A dimer-The data presented here are not consistent with a con-
formational model of signaling through individually en- ization model of signaling has been widely discussed
as a possible early trigger of T cell activation since itgaged TCRs. This is because monomeric MCC/IEk fails
to activate T cells at a concentration 20,000 times higher was first proposed by Brown et al. (1993) based on
their observation that the class II MHC molecule, DR1,than stimulatory doses of MCC/IEk tetramer, despite the
fact that occupancy of TCR by MCC/IEk should be much crystallized as a dimer of the heterodimer with a symme-
try that could allow simultaneous engagement of twohigher under these conditions (see Experimental Proce-
dures and Table 1). These arguments exclude occu- TCRs on a cell surface. A similar observation has been
made with the class II molecule, DR3 (Ghosh et al.,pancy, as opposed to clustering, as a reason for the
much greater potency of tetramer versus monomer and 1995). In contrast, an IEk crystal structure had a dimer
possessing a symmetry inconsistent with coligation ofdimer. The presence of the CD4 coreceptor on T cells
should not significantly alter these occupancy esti- two TCRs (Fremont et al., 1996), and several other class
II crystal structures have lacked dimers (Dessen et al.,mates, since the GK1.5 antibody only marginally inhibits
FACS staining of 5C.C7 and 2B4 T cell lines with MCC/ 1997; Fremont et al., 1998; Scott et al., 1998). Abastado
et al. (1995) used an antibody to create dimers of a classIEk tetramers (data not shown). A lack of CD4 enhance-
ment of MHC-tetramer binding to T cells has also been I MHC-peptide complex and found that these stimulate
IL-2 production in a T cell hybridoma and seratonin re-recently reported by Crawford et al. (1998). Neverthe-
less, it is clear from the data shown here that stimulation lease from a basophil transfectant. However, they also
showed that higher-order aggregates in such prepa-by MHC tetramers is CD4 dependent. This discrepancy
between CD4's role in activation versus binding is con- rations contained more activity than isolated dimers
(Abastado et al., 1995). Although not titrated, the con-sistent with evidence that coreceptors may interact by
a sequential mechanism with preformed Ag/MHC-TCR centration of size-fractionated dimers used to activate
T cells was apparently far greater than those concentra-complexes (Hampl et al., 1997) and possibly in a substoi-
chiometric manner (Garcia et al., 1996). Additionally, tions reported here for tetramers (Abastado et al., 1995).
Any intrinsic stimulatory activity in our dimers seems toAbastado et al. (1995) has also shown that monomeric
class I MHC-peptide complexes were inactive at stimu- be present at levels too low to be physiologically rele-
vant. In contrast to our results, Abastado et al. (1995)lating T cells. To date, available crystallographic data
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report that dimers induce full signals. This discrepancy those receptors that lack intrinsic kinase activity. Unlike
most receptors that are paired with a specific ligandmay be explained by their longer assays, which could
allow Ag/MHC-TCR dimers to further aggregate by diffu- and respond only to this ligand, antigen receptors must
distinguish between a large number (.2000) of self andsion on cells into larger clusters. Alternatively, the strep-
tavidin backbone used here may create a less optimal non-self ligands of very similar chemical composition.
Indeed, other antigen receptors on B lymphocytes (sur-alignment of TCRs than the antibody approach.
The large increase in activity of tetramer versus dimer face immunoglobulin and Fc receptor) may also transmit
signals to the inside of the cell by a clustering mecha-suggests an interesting alternative to a dimerization-
based mechanism: that the colocalization of at least nism (reviewed in Alberola-Ila et al., 1997; Reth and
Wienands, 1997; Daeron, 1997). Clustering, with its in-three TCRs is required to form a critical level of signaling,
as seems to occur for the TNF receptor (Banner et al., herent time lag, may filter out the transient irrelevant
interactions that occur when a T cell scans another cell1993). The significantly diminished activity of the MCC/
IEk trimer, relative to tetramer, is also consistent with during immune surveillance. As previously suggested
(McKeithan, 1995; Rabinowitz et al., 1996a), the separa-TCR trimerization as a critical event, since all possible
combinations of three MCC/IEk complexes are active on tion of binding and signaling by several steps (oligomer-
ization included) can explain the TCR's ability to finelythe tetramer compared to only one on the trimer.
Unlike growth-factors that contain two receptor bind- discriminate, both quantitatively and qualitatively, be-
tween chemically similar antigens that differ only mod-ing sites per molecule, a single TCR engages only one
Ag-MHC complex at a time; therefore, there is no reason estly in their binding affinities.
to suspect that clustering of TCRs should end with di-
Experimental Proceduresmers or trimers. A gradient toward more complete acti-
vation could occur with the formation of larger clusters,
Synthetic Peptidesas suggested here by the calcium flux experiments. Sup-
Synthetic peptides were prepared by the Stanford Protein and Nu-
port for such a model comes from work by Dintzis and cleic Acid Facility by FMOC chemistry and confirmed by amino acid
colleagues who used defined polymers of hapten to analysis and mass spectrometry. MCC peptide (residues 88±103)
was ANERADLIAYLKQATK. MCC(99A) contained an Ala instead ofstimulate hapten-specific T cells (Symer et al., 1992).
the highlighted Lys residue. MCC(102S) and MCC(102G) containedThey conclude that a minimal number of antigen recep-
a Ser and Gly, respectively, instead of the highlighted Thr residue.tors must be cross-linked to form an ªImmunon,º or
Hb (bdmin residues 53±76) peptide had the sequence AIMGNPKVKAHessential immunogenic signaling structure (Dintzis et al.,
GKKVITAFNEGLK.
1989; Symer et al., 1992). More recently, Rotzschke et
al. (1997), using polypeptide oligomers of peptide anti- Proteins
Recombinant IEk containing a single C-terminal 15 amino acid bio-gens to cross-link MHC molecules on the cell surface,
tinylation site was produced as described elsewhere (Altman et al.,showed that higher order oligomers gave better T cell
1993, 1996) with the following changes. Inclusion bodies containingactivation, reaching a plateau at about 16 antigenic pep-
IEk chains were prepared from the BL21(DE3)pLysS strain of Esche-tide units. More directly, Reich et al. (1997) recently
richia coli, by repeated freeze/thaw/wash cycles in 50 mM Tris (pH
showed that productive Ag-MHC/TCR complexes can 8.0), 1 mM EDTA, 25% sucrose, 1% Triton X-100, and 1 mg/ml
self-associate in solution to form supramolecular struc- Lysozyme. The inclusion body preparation was then dissolved in
5.8 M guanidine-HCl, 50 mM Tris (pH 8.8), and 2 mM EDTA. Chainstures containing six or more primary complexes. Thus,
were allowed to oxidize individually to form disulfide bonds for 5±7the Ag-MHC/TCR complex has an affinity for itself that
days at less than 1 mg/ml in this buffer. Following concentration,neither TCR nor MHC alone possesses, making the half-
folding was initiated by combining and diluting subunits to 2 mM inlife of the antigen-specific binding event a determinant
50 mM sodium phosphate (pH 7.5), 25% glycerol, 5 mM reduced
of the degree of clustering. The puzzle of how specific glutathione, 0.5 mM oxidized glutathione, 0.5 mM EDTA, 0.1 mM
Ag/MHC-TCR complexes accumulate in a cluster in the PMSF, 1 mg/ml pepstatin and leupeptin, and 10 mM antigenic pep-
tide. After 4±5 days of incubation at 48C, correctly folded peptide/presence of a large excess of irrelevant antigen could
IEk complexes were isolated by immunoaffinity chromatography onthen be explained by their longer half-lives (Reich et al.,
a 14.4.4 MAb column. Ag/IEk complexes were then enzymatically1997). The appeal of such a model is that the sensitivity
biotinylated as described (Altman et al., 1996) except that proteaseand range of T cell responses to antigen can be ex-
inhibitors were included and the protein was later size purified to
plained largely by kinetics and the resulting differences remove aggregates and free biotin. Biotinylation was confirmed by
in the degree of clustering. An example shown here is a gel-shift assay using excess streptavidin and 10% SDS-PAGE gels
that a partial agonist tetramer containing only a 7-fold- under nondenaturing conditions and was typically greater than 75%.
weaker monomeric interaction [MCC(102S) versus MCC]
Preparation of Oligomersis reduced in activity approximately 500-fold relative to
An FPLC Superdex-200 column (10/30) was used for all gel filtrationwild-type tetramer, presumably because of a diminished
steps below. Streptavidin was purchased from Prozyme, Inc. (San
ability to kinetically drive TCR clustering. The serial en- Leandro, CA). In initial studies, stimulatory activity was found in
gagement of many TCRs by a few Ag/MHC complexes MCC/IEk-only prior to gel filtration, indicating that great care had to
may also explain the high antigen sensitivity of T cells be taken to remove aggregates. Given their relative potencies, it is
clear that less than 0.01% contamination of a tetrameric aggregate(Valitutti and Lanzavecchia, 1997).
in an MCC/IEk preparation can account for significant activity. There-What is the advantage of signaling by a receptor clus-
fore, streptavidin and Ag/IEk-biotin were size purified before re-tering mechanism? The colocalization of TCRs may
acting, after which oligomers were size purified again just beforeallow sufficient cross-phosphorylation to occur, a reac-
use. Size purification of MCC/IEk tetramer immediately prior to ex-
tion that is thought to be very dependent on steric con- periments and without subsequent reconcentration did not remove
straints and local substrate concentrations (reviewed in its stimulatory activity. The 55 kDa form of streptavidin adsorbs
strongly to the FPLC column in PBS and eluted late. Tetramers wereOrtega, 1995) and may be of particular importance for
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prepared by adding streptavidin in several steps to a 20%±40% Calcium Imaging
The 5C.C7 T cell line and the primary 2B4 lymphocytes were calciummolar excess of Ag/IEk-biotin over biotin binding sites and isolating
by gel filtration. SA-linked monomers and dimers were produced at imaged similarly to that described elsewhere (WuÈ lfing et al., 1997).
CHO cells, either untransfected or transfected with native IEk as aapproximately a 60/40 ratio by a single reaction using a 3- to 4-fold
molar excess of streptavidin over MCC/IEk-biotin (12- to 16-fold positive control, were grown to confluency on cover slips (4.8 3 6.0
cm). Cover slips with CHO-IEk were pulsed overnight with MCCexcess of biotin binding sites). MCC/IEk dimer required one addi-
tional gel filtration step before use but probably contained small peptide at 25 mM. Cover slips were then joined to a custom made
flow chamber to form the bottom of the imaged well (height, 0.26amounts of contaminating trimer and tetramer because in one ex-
periment a third gel filtration step significantly reduced its T cell mm; width, 5 mm; length, 40 mm). Fura-2-loaded T cells (15 ml),
either alone or immediately after mixing 1:1 with IEk oligomer, werestimulatory activity. Tetramers and dimers eluted as expected for
their size, indicating that the attached IEk was sufficient to correct injected into the cell chamber by aspiration. T cells that settled
onto the CHO focal plane were analyzed individually for intracellularthe adsorbing tendency of streptavidin. Streptavidin-linked mono-
mer showed some residual adsorbing behavior, eluting slightly later calcium levels as described (WuÈ lfing et al., 1997). In Table 2, full
signals refer to elevations in intracellular calcium that are sustainedthan IEk, and required no further purification. The composition of
these oligomers was confirmed by SDS-PAGE and by BIAcore bind- for several minutes and typically involve a single trigger point. Partial
signals may or may not be repetitive in nature but are of relativelying kinetics. For MCC/99A mixed oligomers, monomer was formed
by first making MCC/IEk monomer as described above and then short duration and returns to baseline (WuÈ lfing et al., 1997). The lag
time between mixing of MHC samples and T cells and the start ofreacting with excess MCC(99A)/IEk-biotin. Dimer and trimer were
prepared by first making MCC(99A)/IEk monomer and dimer as de- data collection was typically less than 30 sec.
scribed for MCC and then reacting with MCC/IEk-biotin. These mixed
tetramers were then purified by gel filtration. Protein concentrations Acknowledgments
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